Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;104(1):38-42.
doi: 10.1016/j.contraception.2021.03.033. Epub 2021 Apr 17.

The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States

Alice Mark  1 , Angel M Foster  2 , Jamila Perritt  3
Affiliations

The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States

Alice Mark et al. Contraception. 2021 Jul.

Abstract

The COVID-19 pandemic disrupted health care delivery in all aspects of medicine, including abortion care. For 6 months, the mifepristone Risk Evaluation and Mitigation Strategy (REMS) was temporarily blocked, allowing for the remote provision of medication abortion. Remote medication abortion may become a dominant model of care in the future, either through the formal health system or through self-sourced, self-managed abortion. Clinics already face pressure from falling abortion rates and excessive regulation and with a transition to remote abortion, may not be able to sustain services. Although remote medication abortion improves access for many, those who need or want in-clinic care such as people later in pregnancy, people for whom abortion at home is not safe or feasible, or people who are not eligible for medication abortion, will need comprehensive support to access safe and appropriate care. To understand how we may adapt to remote abortion without leaving people behind, we can look outside of the U.S. to become familiar with emerging and alternative models of abortion care.

Keywords: Abortion; Food and Drug Administration (FDA); Mifepristone; Misoprostol; Risk Evaluation and Mitigation Strategy (REMS); Self-managed abortion.

PubMed Disclaimer

References

    1. Raymond EG, Grossman D, Mark A, Upadhyay UD, Dean G, Creinin MD, et al. Commentary: no-test medication abortion: a sample protocol for increasing access during a pandemic and beyond. Contraception. 2020;101(6):361–366. - PMC - PubMed
    1. National Abortion Federation . NAF; Washington, DC: 2020. Clinical Policy Guidelines for Abortion Care.https://prochoice.org/education-and-advocacy/cpg/ Available from:
    1. Chong E, Shochet T, Raymond E, Platais I, Anger H, Raidoo S., et al. Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic. Contraception. 2021 forthicomingIN THIS ISSUE. - PMC - PubMed
    1. ACLU. Federal court blocks FDA restriction that unnecessarily imposes CoVID-19 risks on patients seeking abortion care, https://www.aclu.org/press-releases/federal-court-blocks-fda-restriction...; 2020. [accessed 26 February 2021].
    1. Nash E, Dreweke J. The U.S. abortion rate continues to drop: once again, state abortion restrictions are not the main driver. Guttmacher Policy Rev. 2019;22:41–48.

Substances